Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) has announced its participation in the Sidoti Small Cap Virtual Conference on September 18th, 2024. Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will represent the company with a presentation scheduled for 9:15 am ET.

The presentation will be webcast live through the investor relations section of Harvard Bioscience's website. A replay will be available shortly after the presentation concludes. Interested parties can schedule one-on-one meetings through the conference organizers.

This event provides an opportunity for investors to gain insights into Harvard Bioscience's operations and future prospects directly from its top executives.

HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18^th, 2024, with a presentation time of 9:15 am ET.

The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website: https://investor.harvardbioscience.com/events-and-presentations. A replay will be available on the company’s website shortly after the presentation has concluded.

To schedule a one-on-one meeting, please contact the conference organizers directly.

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at www.harvardbioscience.com

Company Contact:
Harvard Bioscience
Jen Cote, Chief Financial Officer
(508) 893-3120

Investor Contacts:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207

FAQ

When is Harvard Bioscience (HBIO) participating in the Sidoti Small Cap Virtual Conference?

Harvard Bioscience (HBIO) is participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation scheduled for 9:15 am ET.

Who will be representing Harvard Bioscience (HBIO) at the Sidoti Small Cap Virtual Conference?

Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will be representing Harvard Bioscience (HBIO) at the Sidoti Small Cap Virtual Conference.

How can investors access Harvard Bioscience's (HBIO) presentation at the Sidoti conference?

Investors can access Harvard Bioscience's (HBIO) presentation through a live webcast on the investor relations section of the company's website: https://investor.harvardbioscience.com/events-and-presentations.

Will there be a replay available of Harvard Bioscience's (HBIO) Sidoti conference presentation?

Yes, a replay of Harvard Bioscience's (HBIO) presentation at the Sidoti conference will be available on the company's website shortly after the presentation concludes.

How can investors schedule one-on-one meetings with Harvard Bioscience (HBIO) at the Sidoti conference?

Investors interested in scheduling one-on-one meetings with Harvard Bioscience (HBIO) should contact the Sidoti Small Cap Virtual Conference organizers directly.